Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Clinical trial NCT02084563 · COMPLETED

Trial details

NCT number: NCT02084563
Sponsor: Hospital Israelita Albert Einstein
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm

Start date: 2012-10-01
Primary completion: 2014-12-01
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.